Invokana is a drug used for treatment of type-2 diabetes that has recently become the topic of many lawsuits in North America. The purpose of the drug is to maintain blood sugar levels in the patient by forcing the kidneys to release excess sugar through urination. This causes more stress on the kidneys than what is typically put on them without the drug. The Invokana lawsuit is growing everyday as more patients have been affected by the drug.
What is the reason for the lawsuits?
According to the FDA there have been 19 filed claims of people who developed blood and kidney infections as a result of Invokana. According to Digital Journal, all of the patients filing the Invokana lawsuit alleged to have required hospitalization and kidney failure treatment with dialysis. The first side effect that can cause serious health issues is an increase in the amount of acid in the blood, as well as Urinary Tract Infections (UTI). These harmful side effects have led to the hospitalization of many Invokana users. Another serious side effect of the drug is Ketoacidosis. In another post by Digital Journal, many patients have filed lawsuits against manufacturers claiming that the drug causes severe side effects and that the companies were negligent in communicating the risks associated with the drugs.
What is Ketoacidosis?
Ketoacidosis is defined by the FDA as “a serious condition in which the body produces high levels of blood acids called ketones. Symptoms of ketoacidosis include nausea, vomiting, abdominal pain, tiredness, and trouble breathing. Patients should also be alert for signs and symptoms of a urinary tract infection, such as a feeling of burning when urinating or the need to urinate often or right away; pain in the lower part of the stomach area or pelvis; fever; or blood in the urine.” If you have experienced symptoms of Ketoacidosis, you should contact a doctor immediately.
The story is a pretty well-known one by now: Zofran was created in 1991 by medical manufacturing giant GlaxoSmithKline and grew to become one of the most popular drugs ever. The actual medication works by limiting the amount of serotonin that gets to the part of the human brain that triggers nausea and vomiting. Obviously this is the kind of thing that a pregnant mother would love. Unfortunately the FDA only permitted the use of Zofran to surgery and cancer patients—not pregnant women. Additionally, reports now allege that GlaxoSmithKline knew the product could be potentially hazardous to pregnant mothers and could cause birth defects. The reality is pregnant women did take the medication and sadly many birth defects occurred, including musculoskeletal abnormalities, club foot, cleft lip, cleft palate, jaundice and heart deficiencies. This has caused a number of Zofran lawsuit claims to be filed.
Similar charges were brought by the Department of Justice, in one of the largest alleged health care fraud in history, a case GlaxoSmithKline settled for $3 billion. What is more stunning is additional plaintiffs have come forward now claiming the company has hid evidence of Zofran’s alleged link to major birth defects for more than two decades.
If you are interested in the December 2014 study that showed the impact of the drug on young mothers from Dr. Gideon Korenin in the American Journal of Obstetrics and Gynecology you can find that here.
The U.S. Food and Drug Administration [FDA] issued their formal warnings and instructions on Zofran here.
When lawsuits are brought against a pharmaceutical manufacturer such as GlaxoSmithKline, they either end in a financial settlement for the plaintiff or the lawsuits go to trial. Generally, zofran lawsuit claims are settled prior to a trial. Medical Claim Legal and its experts have assisted Zofran lawsuit plaintiffs in similar claims.
As Xarelto continues to spend millions of dollars in TV and mass media, another stream of money continues to follow the blood thinning medication—the dreaded Xarelto Lawsuit. With over 5,000 federally-filed lawsuits from across the United States against the manufacturer, consumers are finally getting the compensation they deserve for the patient deaths associated with the product—which prevents and treats blood clots. What’s more staggering is the blood thinner accounted for $1.8 billion in US sales in 2015 alone. A recent story revealed by The New York Times’ Katie Thomas also suggests that the drug’s developers, Johnson & Johnson and Bayer, may have left out some critical data when a peer reviewer at the New England Journal of Medicine asked for it.
What is Xarelto
Rivaroxaban, better known as Xarelto, is a prescription drug used to treat various medical issues. Most of its uses are related to blood clotting. While the drug has been deemed successful in stopping strokes caused by clotting, negative side effects can happen. Some of these side effects are not noticed until you stop using the drug.
What is the Xarelto Lawsuit and Why Are People Filing it?
The side effects from using this blood thinning prescription drug are at the center of many Xarelto Lawsuits around the country. The leading reason for filing these cases is that the pharmaceutical manufacturers marketed and promoted the drug without disclosing the costly side effects that go along with its use. When a company markets a drug and does not explain the risks associated with the use of their drug, it is considered negligence. The Xarelto Lawsuit specifically is causing consumers angst because additional materials are just recently coming to light including the potential cover-up of the drug’s research.
The aforementioned Xarelto commercial with Arnold Palmer and others. Plus a Xarelto Lawsuit Update.